ARCHIVES

Amgen, Genentech Drug Giveaway Programs Likely to Meet Resistance From Doctors, Potential Problems at CMS.

This article is from The Cancer Letter archive.

Vol. 32 No. 36 | October 13, 2006

Download PDF Visit The Full Archive

Related Articles

Patents: Myriad Patents Spectrometry To Assess DNA Polymorphisms

March 5, 1999

California Weighs Listing Tamoxifen As Carcinogen

October 27, 1995

Herceptin With Adjuvant Chemo Improves Disease-Free Survival, Phase III Trial Finds

January 29, 2010

Clinical Research; Duke Received Several Warnings from OPRR, Letters Indicate

May 14, 1999

DoD Ovarian Cancer Research Program seeks proposals for FY05 funding.

October 1, 2004

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987